ComplyRx
Built by ComplyRx

Compare clinical trial pipelines, export for presentations

tarlatamab (16) vs zanubrutinib (16)29 active2017–2039
tarlatamabzanubrutinib
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruitingCompletedUnknown status
'17
'19
'21
'23
'25
'27
'29
'31
'33
'35
'37
'39
tarlatamab
DeLLphi-301P2
DeLLphi-304P3
DeLLphi-306P3
DeLLphi-305P3
DeLLphi-309P2
Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI TreatmentP2
DeLLphi-312P3
Study of How Safe and Effective Tarlatamab is in Brain CancersP2
DeLLightP2
RAGNARP2
TARLANECP3
START-lungP2
DSC-NECP2
DeLLphi-315P3
REPLATP2
PrE0512P3
zanubrutinib
ROSEWOODP2
MAGNOLIAP2
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) TreatmentP2
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin LymphomaP3
BRUIN-MCL-321P3
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS LymphomaP2
R-ICE+XP2
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaP2
Pola-ZR2P in Previously Untreated DLBCLP2
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCLP2
ZeTAP2
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular LymphomaP2
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell MalignanciesP2
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLLP3
GUIDANCE-10P2
ZEN-CLLP2

Upcoming readouts

25 ahead · 2 drugs

Select a trial to load its full ClinicalTrials.gov record.

Trial Pipeline · How it works

Search, compare, export.

Three steps from drug name to a presentation-ready pipeline view, with live trial data, side by side.

  1. 01 · SEARCH

    Search drugs

    Type a drug name and see the phase 2-4 trials from ClinicalTrials.gov.

  2. 02 · COMPARE

    Compare timelines

    See start dates, primary completions, and status on one timeline, up to five drugs at once.

  3. 03 · EXPORT

    Export for your deck

    Download a branded PNG or PDF. Share the URL. Every comparison state is linkable.

FAQ

Where does the data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov). Results are cached for up to 6 hours so repeat loads stay fast.
Is this free?
Yes. Compare up to five drugs and export PNG or PDF at no cost. Export requires a one-time email to join the ComplyRx waitlist.
What is ComplyRx?
ComplyRx is an all-in-one marketing/competitive intelligence platform for organisations and individuals that work in healthcare, life sciences, and the pharmaceutical industry.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.